Usability of Laryngeal Vibro-tactile Stimulation as a Non-invasive Treatment for the Voice Disorder Spasmodic Dysphonia
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Spasmodic Dysphonia
- Sponsor
- University of Minnesota
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Perceived voice effort
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The general aim of the study is to provide evidence for usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (SD). This work addresses a clinical need to develop alternative or auxiliary treatments for a rare voice disorder with very limited treatment options. Successful completion of the proposed work will be an important step in advancing laryngeal VTS as a therapeutic intervention for improving voice symptoms in SD.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of spasmodic dysphonia (laryngeal dystonia) for a minimum of 6 months with documented symptom relief after Botox injection.
- •Diagnosis is made by a voice disorder specialist.
Exclusion Criteria
- •Regular intake of benzodiazepines
- •Cognitive impairment: score \< 27 on Mini-mental state examination
- •Identifies with a neurological or musculoskeletal impairment affecting speech motor function. These impairments may include a form of: Dyskinesia, Dystonia, Essential Tremor, Huntington's Disease, Multiple System Atrophy, Muscle Tension Dysphonia, Parkinsonism, Progressive Supranuclear Palsy, Spasticity, Intracranial Neoplasm (brain tumor), Spinal Neoplasm, Cerebrovascular Accident (Stroke), Mild Traumatic Brain Injury, Intracranial Hemorrhage, Multiple Sclerosis
Outcomes
Primary Outcomes
Perceived voice effort
Time Frame: 8 weeks
Participants will rate their perceived effort level of vocalization on an ordinal scale of 0 to 10 (0 being with no effort and 10 being with maximal effort). The recordings will provide subjective impression of treatment.
Secondary Outcomes
- The duration of voice break(8 weeks)
- The number of voice breaks(8 weeks)